Health and population

Health and population dynamics are intertwined, embodying an intricate relationship with significant implications on the Sustainable Development Goals (SDGs). Health is fundamentally at the center of these 17 global goals, aimed to transform the world by 2030. Specifically, Goal 3 endeavors to "Ensure healthy lives and promote well-being for all at all ages." It acknowledges that health is pivotal to human life quality, social cohesion, and sustainable development. Inextricably linked to this are the complexities of population dynamics, including growth rates, age structure, fertility and mortality rates, and migration patterns.

With the world's population projected to exceed 9.7 billion by 2050, the pressure on health systems will undoubtedly escalate. The demographic transition, with an aging population and an increasing prevalence of non-communicable diseases, poses new challenges for health systems globally. Additionally, areas with high fertility rates often overlap with extreme poverty, resulting in heightened health risks, including higher maternal and child mortality rates, malnutrition, and infectious diseases.

Moreover, rapid urbanization and migration present both opportunities and threats to health. While urban areas may provide better access to healthcare, they also harbor risks of disease transmission, air and water pollution, and social determinants of health like inadequate housing and social inequality. Simultaneously, migrants often face disproportionate health risks due to unstable living conditions, exploitation, and limited access to healthcare services.

Achieving the SDGs will necessitate comprehensive approaches that consider the intricate interplay of health and population dynamics. It means strengthening health systems, promoting universal health coverage, and addressing social determinants of health. It also implies crafting policies that recognize demographic realities and foster an environment conducive to sustainable development. Only by understanding and harnessing these dynamics can the world meaningfully progress towards realizing the SDGs, ensuring healthy lives and well-being for all.

This book chapter advances SDG #3 and #10 by focusing on polyphenols and flavonoids and their crucial role in decreasing AD symptoms. In addition, it highlights the neuroprotective role of various essential ingredients of plant extracts such as Icariside, Onjisaponin B, Asarones, Liquiritin, Tanshinone IIA (TIIA) and cryptotanshinone (CT), Ginsenoside Rg1, and n-Butylidenephthalide. The efficacy of green nanotechnology are also discussed.
This Article supports SDG 3 by assessing the association between people leaving state in the USA for an abortion and the availalble facilities and state legislation. THe findings showed that the proportion of people leaving the state varied widely by state, and that this was affected by state-level abortion policy and facility scarcity.
This Article supports SDGs 3 and 16 by evaluating the ability of artificial intelligence to recognise a person's racial identity from medical images.
Elsevier,

Plant Extracts in Neurodegenerative Diseases, First Edition, 2022, pp 1-15

This chapter advances the UN SDG goals 3 and 17 discusses how plant extracts can help decrease AD symptoms.
This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by examining how and why social determinants differentially impact health, healthcare, and health outcomes.
Elsevier,

Nanotechnological Applications in Virology, Developments in Applied Microbiology and Biotechnology, 2022, Pages 195-218

This chapter aligns with the SDG goal 3 of good health and wellbeing by showing the role of nanotechnology in the diagnosis, treatment, and development of vaccines of these viral diseases. Nanotechnology could be a great ally for a new way to fight these viruses and treat these diseases.
This Article supports SDG 3 by investigating the role of CD8+ T cell count on suppressive ART as a predictor of clinical progression in HIV, suggesting its potential use as a clinical biomarker in evaluations of novel therapies for ongoing immune dysfunction during treated infection.
This Article supports SDG 3 by providing new insights on the degree and determinants of real-world PrEP effectiveness among men at risk of HIV in France, with relevance in the current context of worldwide PrEP scale up.
This Article supports SDGs 3 and 6 by assessing the level of hand hygiene implementation and its drivers in health-care facilities through a global WHO survey; 25% of health-care facilities in low-income and middle-income countries were found to lack basic hygiene services, including access to clean water.
Elsevier,

The Lancet Infectious Diseases, Volume 22, June 2022,  P845-856

This study supports SDGs 3 and 6 by reporting findings from the first WHO global survey assessing infection prevention and control programme implementation at the facility level, and highlighting key gaps: for example, only 68% (302 of 446) of low-income countries had continuously available water services.

Pages